疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

" _9 u2 X2 X( E. R5 SApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
6 p; G- E; x, X
) [2 c* Y" ^' nSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
) J3 h/ q5 }4 K: }3 V  Q5 X3 The vaccine industry 33
; o! X  |( ], z( A% J9 R# ?( a; G4 Vaccine manufacturing 44
, z; Q0 ?* Q2 g+ a9 A2 y1 B0 F& V* ^0 T5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
3 ?9 L: m' q: ]6 j. D5 Xlicensed vaccines 71
7 Passive immunization 80
" ^9 n& e7 ~; j9 p8 General immunization practices 88
1 A/ K9 Q7 E& \. J; @SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
: E& E  R) U& P0 T  n  J; W3 Z11 Cholera vaccines 141
) g( r' J- J& ?/ j# N& `12 Diphtheria toxoid 153
/ A7 \. q: y& s. m* {( J9 b- g1 U13 Haemophilus influenzae vaccines 167
5 l6 I! k, ]4 P/ e14 Hepatitis A vaccines 183
. e7 V( D/ _# D" p15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
, x( O! D! Q% U0 g; D* L17 Inactivated influenza vaccines 257
# c& o5 \! g3 |2 g  u18 Influenza vaccine-live 294
4 v+ n, ~0 ^2 U5 A19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
: e" @) p( D; A; B21 Meningococcal vaccines 388
, W: D; `7 c! K+ F6 u22 Mumps vaccine 419
& [$ N- A3 G& V/ S23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
9 D5 _7 ~  t( F$ U26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
7 J5 B2 _3 T. T* V- P4 h" N; K. b28 Poliovirus vaccine-live 598
( N9 W/ \3 |  g29 Rabies vaccines .646
# ?* A/ a" S  W* ?3 Q: p30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
3 Q! I( F; `' L" ~  ^) B  X34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
2 c9 O0 }2 @3 m9 n5 q- @. h36 Typhoid fever vaccines 812
+ r1 ]. v2 b8 E- c  x6 H& ^$ T1 Y37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
2 \4 L/ S" C. w7 \9 v4 u40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
; x$ Z" W' x- E41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
; w9 Z9 `, P$ D. U44 Dengue vaccines 1042
6 p. q# n9 l( d6 L& Y- x45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
$ V) d( b; d  H- Y2 _/ R47 Epstein-Barr virus vaccines 1068
7 O; I, e8 @9 e8 G48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
2 F1 S( s4 f* Z, u6 }51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
8 B2 t5 @4 x( ?: Q- z0 U* v+ C53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
" r! ^5 C3 S5 o. U/ t! N9 X/ Y55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
7 Q2 }3 b  s# D: V& \3 ^& v56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
  u* v  @3 U3 V7 F58 Streptococcus group A vaccines 1169
! |' _4 A" {, u7 w- K59 Streptococcus group B vaccines 1176
# f8 k* F; X0 T  r60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
3 O1 [4 c2 Q/ ~  Z62 The development of gene-based vectors for immunization 1232
/ l: v- Z; \4 TSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
, g1 j8 B4 m- T% G64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
) \4 T5 F" Y3 q  T' \66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
' i7 u' _1 F( h68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
7 a; F/ o/ h  B# c, m" y71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
2 {) f5 R0 N, J4 B# I2 P4 D$ J74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
7 n9 M/ p  C. O* Q2 N

+ O# }8 a6 ]$ T! t
7 s3 Q: N2 B4 T5 N* p- {' {1 C4 n. G

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

& S2 K7 U$ o3 z  b7 KVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
/ N- r6 Y% e; m% [& A
  f7 c; o8 W3 B" N' k' bhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
2 n, p/ Q$ \  o& ^/ }+ D$ `* Y. v
& P& Y& D. S! }+ ?SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
4 o  ?; W" o* W5 N  n2 Vaccine immunology 14
6 A- A# u0 D) b6 C& V4 }4 B. u# j& \3 The vaccine industry 33
0 N& l, B( e7 c' C; ?/ [4 Vaccine manufacturing 44
8 S6 W6 a; _; J# b5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
4 x* r' x! C8 P# o2 plicensed vaccines 71
5 |5 [# C, y0 @% n7 w7 Passive immunization 80
; A9 a: f  M- K; }8 General immunization practices 88
SECTION 2: Licensed vaccines
9 p! ~( h5 C( \5 l9 Adenovirus vaccines 113
- `" m% Y# \! e* h) ~10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
' @) ^+ b1 }8 d) S$ t3 h$ }14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
; l; O) e- d1 x+ m3 D; Y16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
' ^+ r3 r- c0 I- K( J18 Influenza vaccine-live 294
5 o& {+ `+ A2 Y- p7 p$ ^19 Japanese encephalitis vaccines 312
$ s7 z$ M1 S% D% T20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
$ A4 i  B* U) |  _24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
' Q' |0 _# s- i: {6 e27 Poliovirus vaccine-inactivated . 573
! D; s+ u+ Q" A: U/ f6 U8 H28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
. x! T9 w, U; C( T9 J3 S" C/ v32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
! J, q4 j% C3 a$ S35 Tuberculosis vaccines 789
# s4 n2 x, B( G$ \3 p: J& I( D4 S36 Typhoid fever vaccines 812
37 Varicella vaccine 837
% A& y1 u9 ^$ @' m38 Yellow fever vaccine 870
, V, o& k; x. f39 Zoster vaccine 969
' o( M) u# k+ d5 _1 D1 E( {. B: x, b; `40 Combination vaccines 981
9 t$ c  Q/ O* X% @8 n2 _& OSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
) _  D$ t3 ~) ]  S7 q; i42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
% t, Q2 Q! L4 R9 b- V$ f/ f0 r, n45 Diarrhea caused by bacteria 1052
$ M8 H1 B/ |6 P' X, X! L$ z  V( f  i46 Ebola vaccine 1060
/ V+ w% z) m) ?( v, K2 R47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
' b2 s3 R) u" g0 f9 W4 f49 Hepatitis E vaccines 1085
; \% ]8 k8 K0 C" Y* o6 Z50 Herpes simplex virus vaccines 1090
2 m. z5 k* {! l# }" r51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
7 ~1 }/ E& N0 B# N  i53 Malaria vaccines 1133
) v" t; O8 c" L' J  C! U" m! ?54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
  f+ s* M4 ]8 ~2 v: s0 Y( i* D61 Alternative vaccine delivery methods 1200
+ N5 L' b( U2 \. K' X! P1 z+ W62 The development of gene-based vectors for immunization 1232
& o* Y7 l  W1 p" bSECTION 4: Vaccination of special groups
* @- ]9 E* a8 n/ e4 Y63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
# a% D. ^4 D3 n- B. S: ^. p: |( S65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
7 G- G9 s# O$ A! G4 u; OSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
. {, y$ K8 V4 w! y( D68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
+ B! E. |1 O* L7 k- p5 m2 E72 Economic analyses of vaccine policies 1413
1 u+ {1 i7 M! g1 P. o8 [8 ?73 Regulation and testing of vaccines 1427
! `( V) G: `+ U& H74 Regulation of vaccines in Europe 1447
3 C: g4 q+ O1 l! A$ x75 Regulation of vaccines in developing countries 1454
5 z3 [1 `( g* |5 u- }  a- w/ l76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

/ V  O3 A: x3 p* _
! }: l" ]0 l6 {/ T: {% k

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
- f! G) A% @' t) ~" \- C# TPublisher: Saunders; 6 edition (October 30, 2012)
, f: {, p9 y% [& ]Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)
% O3 K' h; f# X0 Z% W
2013 BMA Medical Book Awards Highly Commended in Public Health!
9 \7 E' W0 Q' K6 d. ?& TApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

% ?" k& b6 O, E5 k: C# ?& @Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
6 o/ D% }6 F4 y: EUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
0 k* Z0 V1 ?1 VGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
! B' l6 k) p0 |. f* `( VStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

* j) i$ V9 [; ~8 MDownload link: http://pan.baidu.com/s/1i5NxwLR
. a; l( }/ B. a' g) lCode for downloading: dv96